Christopher Carey

Christopher Carey Recent News

Canopy Growth Analysts Applaud Q3 Report, Stock Rallies: 'Revenue Momentum Has Returned'
Aurora Cannabis Analyst Says Company Needs 'Much Work On Costs'
7 Cannabis Stocks To Buy, Sell And Hold
BofA Says Canopy Growth Should Take Action To Right-Size Costs
Analyst Raises Price Objectives For Cannabis Stocks: 'Higher Multiples Raise The Bar For All'
Organigram Analysts Say Stock's Post-Earnings Rally 'Overdone,' Company Should Add Leverage
Aurora Cannabis Downgraded By Piper Sandler, BofA
Bank Of America Looks At Colorado Sales In Monthly Cannabis Tracker
Canopy Growth Is Prepared For 'Cannabis 2.0' In Canada, Analysts Say
'Worst Looks Over' For Canopy Growth, Bank Of America Says In Upgrade
Canopy Growth Analysts Lower Price Targets After Q2 Report
Canopy Growth Analysts Parse Q2 Print As Investors Retreat
BofA: Cronos Group Has Potential To Be Long-Term Cannabis Leader
Analyst: Canopy Growth Looks Greener Than It Did 6 Weeks Ago
Hexo Analysts React To Resignation Of Cannabis Company's CFO: 'What Don't We Know?'
Bank Of America Upgrades Scotts Miracle-Gro, High On Cannabis Prospects
Bank Of America Downgrades Canopy Growth, Projects 26% Revenue Miss
Aurora Investors Aren't Feeling The Buzz After Q4 Print: 2 Analyst Takes
Tobacco Stocks Rebound As Trump Says 'We Have To Do Something On Vaping'
Bank Of America: There's Still A Canadian Cannabis Bottleneck
Analyst: Cronos-Redwood Deal 'Just The Tip Of The Iceberg'
Bank Of America Downgrades Aurora Cannabis, Concerned About Cash Burn
A Technical Breakdown In Cannabis Stocks